|
Date of decision
|
25 April 1995
|
|
|
Case number
|
T 0906/91
- 3.3.4
|
|
|
Application number
|
83303822.7
|
|
|
|
|
|
|
Title of the application
|
Hybridoma cell lines and monoclonal antibodies to theophylline
|
|
|
Applicant name
|
E.I. DU PONT DE NEMOURS AND COMPANY
|
|
|
Opponent name
|
Behringwerke Aktiengesellschaft
Boehringer Mannhein GmbH Patentabteilung
|
|
|
|
|
Keywords
Inventive step -no; obvious to replace antisera by monoclonal
antibodies with reasonable expectation of improved specificity;
no difficulties overcome in doing so.
|
|
|
|
|